How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks

KEYPOINTS

• 01

  Psilocybin is a tryptamine that mimics serotonin

  Psilocybin is a tryptamine, like DMT and 5-MeO-DMT, and in its active form, psilocin, it closely resembles serotonin. Stomach acidity converts psilocybin to psilocin. Huberman notes that about 90% of the body's serotonin is made in the gut, but brain serotonin comes from separate neurons, not from gut stores.

• 02

  The serotonin 2A receptor is the key

  Psilocybin acts mainly at the 5-HT2A receptor, which sits in specific brain areas and parts of neurons, notably the apical dendrites of cortical pyramidal neurons that connect laterally across regions. That selectivity, rather than general serotonin boosting, is what Huberman says drives both the acute experience and the later circuit changes.

• 03

  Visual hallucinations come from dense 2A receptors in visual cortex

  The visual cortex has very high 2A expression, so at sufficient doses people hallucinate with eyes open or closed. With eyes open, much of the session gets absorbed in outside visuals like geometric fracturing or melting faces. Experts running trials told Huberman that therapeutic benefit depends on keeping the eyes covered for most of the session.

• 04

  Rewiring alone is not the goal; adaptive rewiring is

  Huberman repeats that plasticity is not automatically therapeutic: brain injury and methamphetamine also rewire the brain, maladaptively. The aim is changes that help someone function better afterwards. Set, setting, eyes-closed versus open, music and dose all shape whether the plasticity is beneficial.

• 05

  Psilocybin increases connectivity across brain networks

  Imaging studies show more lateral, less hierarchical communication between brain areas after psilocybin, including at rest. Despite this reduced modularity, Huberman notes that long-term memory problems are rarely reported in depression trials.

• 06

  Plasticity mostly comes from new connections, not new neurons

  Huberman estimates neurogenesis accounts for perhaps 1–2% of meaningful adult rewiring 'and I'm being generous.' Psilocybin's effects in animal models involve growth of dendrites and dendritic spines, which are new sites for excitatory input. He notes that depressed humans show fewer spines in frontal cortex.

• 07

  Dose conversions and the 'heroic dose'

  Mushrooms average about 1% psilocybin, so 1 g of mushrooms holds about 10 mg. A 'heroic dose' of about 5 g therefore equals roughly 50 mg. Potency ranges from about 0.5% to 2% across strains, batches, age and storage, so 1 g could deliver 20 mg, or 3 g only 10–15 mg. Research uses synthetic psilocybin given orally or intravenously. Microdosing in research terms means 1–3 mg daily; therapeutic doses are 10 mg or 25–30 mg, once or twice.

• 08

  A typical session has a predictable arc

  Participants fast for at least four hours, since food changes gut acidity. Effects begin 30–45 minutes after dosing, peak around two hours with intense emotion and often anxiety (part of 'ego dissolution'), and taper toward about six hours. Clinical playlists follow this arc: quiet, mostly instrumental music first, then 45–90 minutes of louder, percussive music at the peak, then softer, melodic or choral music.

• 09

  Extreme anxiety at the peak predicts worse outcomes

  Some anxiety is expected, but extreme anxiety is negatively correlated with relief from depression. That makes trained guides who can help people through it in real time essential.

• 10

  Strict exclusions and cautions apply

  People with psychotic or bipolar tendencies, or even a first-degree relative with bipolar disorder, schizophrenia or schizotypal traits, are typically excluded from trials. Most studies enroll adults aged 25 to about 70. Trials require participants to be off serotonergic antidepressants, but Huberman stresses never stopping medication without a physician or psychiatrist, which he calls potentially catastrophic. Psilocybin remained illegal outside research and some decriminalized areas at recording.